Wellgistics Health converts $8.1M debt to equity, amends acquisition payment terms

Wellgistics Health, Inc.

Remaining $8.14M closing cash payment converted into 7,606,785 shares of common stock; reduces short-term debt.
Promissory notes increased from $15M to $17.5M; $5M due on first and second anniversaries, $7.5M on third.
Strategix (controlled by CEO Brian Norton) to receive 333,333 shares from prior $1.5M cash payment conversion.
Company will reimburse Sellers $12,000 for fees incurred in connection with the amendments.
Press release says conversion strengthens balance sheet, aims to improve cash flow and expand network.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.